Q-Line Biotech Reports H1 FY27 Results with 10% EBITDA Growth and Strategic Acquisition
Q-Line Biotech Ltd · Press Release · 13 Nov 2026, 2:16 am
Q-Line Biotech Reports H1 FY27 Results with 10% EBITDA Growth and Strategic Acquisition Q-Line Biotech reported consolidated revenue of ₹152.18 crore for H1 FY27, up 5.83% YoY, while EBITDA rose 10.02% YoY to ₹39.57 crore with margins expanding 99 bps to 26.00%. PAT declined 8.06% YoY to ₹19.60 crore, impacted by higher depreciation from the newly capitalized Unit 4 facility and finance costs. Reagent sales grew 19.23% YoY and trade business surged 20.13% YoY. Additionally, the Board approved acquiring a 70% stake in Heidelco Medicore for ₹26.63 crore to consolidate operations and drive synergies.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. · 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates · 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Clarification-'.that due to an inadvertent clerical error, the time in the subject line of the filing was mentioned as 3:00 P.M. instead of 4:15 P.M.We hereby clarify that the correct time of the Board Meeting is 4:15 P.M., as mentioned in the Board Meeting notice. The incorrect reference to 3:00 P.M. in the subject line may kindly be treated as an inadvertent error.We regret the inconvenience caused and request you to take the above cl · 06 Nov 2026
